Opioid Drug Sales Online Draw US FDA Warnings, Prompt Summit Meeting
This article was originally published in The Pink Sheet & The Rose Sheet
At June 27 "Online Opioid Summit," FDA officials, pharma sales researchers, and industry stakeholders will discuss collaborating for stronger impact against the opioid crisis by reducing the availability of illicit products online."The internet is virtually awash in illegal narcotics and we’re going to be taking new steps to work with legitimate internet firms to voluntarily crack down on these sales," says Commissioner Scott Gottlieb.
You may also be interested in...
FDA Issues Challenge To Medtech To Fight Opioid Crisis
Echoing President Trump's ongoing call to fight the opioid-abuse epidemic, the US agency is asking medtech companies to submit applications for new products to tackle the issue. Promising devices and diagnostic tools identified by the agency will get extra attention from FDA, but they won't have to submit an additional application for a Breakthrough Device designation.
Smaller OTC Loperamide Packages Wait As Retailers Limit Purchase Amounts
Commissioner Scott Gottlieb updates US FDA's initiative to prevent potentially fatal abuse of OTC loperamide, noting that online and conventional retailers are limiting product purchases while the agency continues evaluating the appropriate number of doses per package.